In the individual SMART trials, there was no evidence of an additive risk with CE BZA and, in fact, there was generally no increase in risk of VTEs, cerebrovascular events, or cardiac events with CE BZA compared with placebo 19, 20, 22, 26 priligy dapoxetine 30mg